Literature DB >> 31809551

Building a network for hemophilia care in China: 15 years of achievement for the Hemophilia Treatment Center Collaborative Network of China.

Renchi Yang1, Man-Chiu Poon2, Koon Hung Luke3, Yongqiang Zhao4, Jing Sun5, Xuefeng Wang6, Runhui Wu7, Lixia Chen4, Xinsheng Zhang8, Jingsheng Wu9.   

Abstract

Entities:  

Year:  2019        PMID： 31809551      PMCID： PMC7034119          DOI： 10.1182/bloodadvances.2019GS121524

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  5 in total

1.  Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia.

Authors:  Richard Huan Xu; Dong Dong; Nan Luo; Eliza Lai-Yi Wong; Yushan Wu; Siyue Yu; Renchi Yang; Junshuai Liu; Huiqin Yuan; Shuyang Zhang
Journal:  Eur J Health Econ       Date:  2021-03-24

2.  Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies.

Authors:  Renchi Yang; Yongqiang Zhao; Xuefeng Wang; Jing Sun; Runhui Wu; Chenghao Jin; Jie Jin; Depei Wu; Pablo Rendo; Feifei Sun; Jeremy Rupon; Francois Huard; Joan M Korth-Bradley; Lihong Xu; Binyu Luo; Yingxue Cathy Liu
Journal:  J Blood Med       Date:  2020-11-25

3.  Medical costs and hospital utilization for hemophilia A and B urban inpatients in China: a national cross-sectional study.

Authors:  Zhengwei Huang; Stephen Nicholas; Yong Yang; Xiaoping Chen; Elizabeth Maitland; Yong Ma; Xuefeng Shi
Journal:  BMC Health Serv Res       Date:  2022-02-19       Impact factor: 2.655

4.  Research on the Impact of Home Nursing Based on Intelligent Medical Internet of Things on the Quality of Life of Patients with Hemophilia.

Authors:  Mengyan Liu; Sufang Zhao; Xiaming Zhu; Ying Chen
Journal:  Comput Math Methods Med       Date:  2022-05-04       Impact factor: 2.238

Review 5.  Factor VIII replacement prophylaxis in patients with hemophilia A transitioning to adults: a systematic literature review.

Authors:  Jing Sun; Xuan Zhou; Nan Hu
Journal:  Orphanet J Rare Dis       Date:  2021-06-26       Impact factor: 4.123
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.